Literature DB >> 30639514

Co-expression of membrane-bound TNF-alpha type 1 and 2 receptors differ in the subsets of immunocompetent cells.

Sergey Sennikov1, Alina Alshevskaya2, Julia Zhukova2, Irina Belomestnova2, Aleksander Karaulov3, Irina Evsegneeva3, Julia Lopatnikova2.   

Abstract

The immunoregulatory cytokine tumor necrosis factor α plays crucial roles in the pathogenesis of a broad spectrum of disorders. However, its effect may depend on the expression and co-expression of receptors on the target cell. The aim of the present study was to evaluate the expression levels of type 1 and 2 tumor necrosis factor α receptors (TNFR1/2) on individual cell subsets from peripheral blood of healthy volunteers. Flow cytometry analysis was used to study whole populations as well as subsets (T regulatory cells, T memory cells, cytotoxic T cells, T helper cells). Significant differences in the co-expression of TNFR1/2 were seen within subsets and total pools. Further studies are necessary to explore the implications of the observed differences in the modulation of tumor necrosis factor α function in health and pathology.
Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cellular immunology; Cytokine receptors expression; Immune regulation

Mesh:

Substances:

Year:  2019        PMID: 30639514     DOI: 10.1016/j.imlet.2019.01.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

Review 1.  Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects.

Authors:  Portia Gough; Ian A Myles
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

2.  Co-Expression Profile of TNF Membrane-Bound Receptors Type 1 and 2 in Rheumatoid Arthritis on Immunocompetent Cells Subsets.

Authors:  Alina Alshevskaya; Julia Lopatnikova; Julia Zhukova; Oksana Chumasova; Nadezhda Shkaruba; Aleksey Sizikov; Irina Evsegneeva; Victor Gladkikh; Aleksander Karaulov; Sergey V Sennikov
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.